Differential effects of Paclitaxel on dendritic cell function
<p>Abstract</p> <p>Background</p> <p>The potential utility of dendritic cells (DC) as cancer vaccines has been established in early trials in human cancers. The concomitant administration of cytotoxic agents and DC vaccines has been previously avoided due to potential i...
Main Authors: | Morgan Richard, Askham Jonathan, Riley Catherine, Ismail Mohammed, John Justin, Melcher Alan, Pandha Hardev |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Immunology |
Online Access: | http://www.biomedcentral.com/1471-2172/11/14 |
Similar Items
-
Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using Attenuated Salmonella typhimurium
by: Agnieszka Michael, et al.
Published: (2010-01-01) -
PBX3 in Cancer
by: Richard Morgan, et al.
Published: (2020-02-01) -
Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK
by: Fairfax Benjamin, et al.
Published: (2006-11-01) -
Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment
by: Katharina A. Sterenczak, et al.
Published: (2021-05-01) -
Gene transfer therapy for cancer
by: Pandha, Hardev Singh
Published: (1998)